http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114924071-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab98cdcd94fd8b69fdbf436257c15f7c |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-916 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-042 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 |
filingDate | 2022-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac3f679c3de03a3166a0a9766b6fe191 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6bf0070c9b384150170027e94b122e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b50afbc7192c2674e1a18b5d24f3ee0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9446abb77ae6f9b22633227e92c8c17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2945f4f4b97d04ba5b91390b97b79b39 |
publicationDate | 2022-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-114924071-A |
titleOfInvention | An anti-tyrosine phosphatase antibody assay kit |
abstract | The invention relates to the technical field of biological analysis, and provides an anti-tyrosine phosphatase antibody assay kit, comprising a reagent 1 and a reagent 2 which are independent of each other, and the reagent 1 is placed in a buffer with a pH of 6.5-7.5 by a stabilizer and a preservative Composition in liquid; Reagent 2 is composed of bovine serum albumin, surfactant, preservative and latex particles coated with tyrosine phosphatase antigen placed in a buffer solution of pH 6-8. The kit of the present invention adopts the latex immune turbidimetric method as the detection principle to determine the serum anti-tyrosine phosphatase antibody. Compared with the current clinical kits, the specificity, sensitivity and accuracy are consistent, and the kit of the present invention is suitable for Large-scale determination on various biochemical analyzers does not require expensive testing instruments, short testing time, convenient operation, low testing cost, and no radioactive pollution. |
priorityDate | 2022-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 116.